Paralleling its drive for greater transparency in hospital and insurer pricing, the Trump Administration is calling for AI to be made more readily understandable in all industries using it, including healthcare.

The shareholders of both Centene and WellCare Health Plans have approved a plan for the two companies to merge, they announced June 24. The deal is worth $17.3 billion and is expected to close in the first half of 2020.

Healthcare stocks are reeling following an executive order from President Trump that would give HHS the ability to require hospitals and health insurance companies to provide patients with prices for healthcare services based on negotiated rates.

As surprise billing solutions are more readily being talked about in Congress and among healthcare leaders in the industry, Americans are blaming their insurance companies for the problem, according to a recent survey from Morning Consult and the American College of Emergency Physicians.

Eyesight researchers have developed a machine-learning architecture whose best model, an ensemble classifier, achieved 93.4% accuracy in separating good candidates for corneal refractive surgery from patients likely to have post-surgery complications or poor outcomes.

Healthcare improvement company Premier has teamed up with a cognitive supply chain company, Pensiamo, to tackle drug supply chain with a new AI-powered solution.

AI is enabling healthcare workers to understand people’s moods with a level of accuracy that may be as unnerving as it is exciting.

Following total hip replacement, patients are well-served with AI-powered biofeedback that helps them rehab safely and effectively at home with occasional monitoring by a remote physical therapist.

HHS has sent its proposal to base certain drug prices on an international index to the White House last week, according to a report from The Hill.

Two major, global pharmaceutical companies ––AbbVie and Allergan––are merging in a deal worth approximately $63 billion.